FSSAI suspends Matri Drinking Water licence, bars Noble Healthcare’s Venolex Forte
FSSAI has suspended Tripura-based Matri Drinking Water’s licence over hygiene and contamination violations. It also barred Punjab-based Noble Healthcare from making or selling Venolex Forte, citing unapproved and pharmacologically active ingredients.
FSSAI suspended Tripura-based Matri Drinking Water's licence over hygiene and contamination violations, and barred Punjab-based Noble Healthcare from making or selling Venolex Forte for containing unapproved and pharmacologically active ingredients.
Why this matters
No related recent signals are listed for Matri Drinking Water; the FSSAI suspension is the available brand-specific regulatory event.
Retail-brand signals are accelerating, up 95,700% QoQ.